Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Eli Lilly
(NY:
LLY
)
877.79
-31.53 (-3.47%)
Official Closing Price
Updated: 7:00 PM EDT, Sep 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Eli Lilly
< Previous
1
2
...
17
18
19
20
21
22
23
24
25
...
99
100
Next >
Aristocrats in Disguise: 3 Blue-Chip Stocks With Stealth Growth Potential
May 31, 2024
These blue-chip growth stocks provide the cornerstone for building a portfolio offerings a wealth of lucrative returns for years.
Via
InvestorPlace
Institutional Bets: 7 Stocks the Big Money Will Send Higher This Year
May 30, 2024
Institutions exert a powerful influence over these institutional favorite stocks that individual investors can benefit from in 2024.
Via
InvestorPlace
New Weight Loss ETF Is Essentially A Play On Eli Lilly, Novo Nordisk
May 30, 2024
New OZEM ETF offers investors exposure to weight-loss sector through top pharmaceutical companies Eli Lilly and Novo Nordisk, with potential for high growth but also risks.
Via
Benzinga
Topics
ETFs
Weight Loss Drug Market To Rocket To $130B By 2030 With Eli Lilly, Novo Nordisk In Lead: Goldman Sachs
May 30, 2024
Goldman Sachs re-rated Eli Lilly and Novo Nordisk, citing potential for weight-loss drugs. Global sales expected to reach $130B by 2030.
Via
Benzinga
Urban Outfitters, Eli Lilly And 2 Other Stocks Insiders Are Selling
May 30, 2024
Via
Benzinga
Could Eli Lilly Be the Next to Join the Trillion-Dollar Club?
May 29, 2024
Today, Eli Lilly's market value tops $700 billion.
Via
The Motley Fool
Blue-Chip Bubble Trouble: 7 Stocks to Short as Valuations Stretch to the Limit
May 30, 2024
Be careful with these overvalued blue-chip stocks, each of which is trading at a high multiple relative to its peers.
Via
InvestorPlace
Nvidia Is Up 186% From A Year Ago, Yet These 7 Stocks Have More Than Doubled Their Returns Over The AI Chipmaker
May 29, 2024
NVIDIA Corp. (NASDAQ:NVDA) has been the standout tech stock of the past year, leading the Nasdaq 100 index in the performance ranking.
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
FDA Conditionally Approves Eli Lilly's Thyroid Cancer Drug For Pediatric Patients With Certain Mutations
May 29, 2024
Accelerated FDA approval for Eli Lilly's selpercatinib (Retevmo) in pediatric patients aged 2+ with advanced/metastatic thyroid cancer & solid tumors carrying RET mutations or fusions.
Via
Benzinga
Exposures
Product Safety
3 Sorry Pharma Stocks to Sell in May While You Still Can
May 29, 2024
Discover three pharma stocks to sell in May while you still can. Avoid these companies facing significant setbacks.
Via
InvestorPlace
Jim Cramer Recommends Buying Apple, Finds This Tech Stock 'Very Interesting'
May 29, 2024
On CNBC's "Mad Money Lightning Round," Jim Cramer said Apple Inc. is a "buy" after iPhone sales in China saw a 52% year-on-year increase.
Via
Benzinga
If You Can Only Buy One Biotech Stock in May, It Better Be One of These 3 Names
May 29, 2024
Between FDA approvals and product pipelines, it takes diligence to keep up with which biotech stocks to buy.
Via
InvestorPlace
Exposures
Product Safety
Weight-Loss Drug Forecasts Skyrocket To $150B As Novo Nordisk, Eli Lilly Ramp Up Supply
May 29, 2024
The global market for weight-loss drugs is expected to reach a staggering $150 billion by the early 2030s, a significant increase from the previous forecast of $100 billion. This surge is attributed to...
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
May 28, 2024
Via
Benzinga
Nvidia's Meteoric Rise: How Does It Compare To Other Market Rallies?
May 28, 2024
Bespoke analysts compared Nvidia to Microsoft, Amazon and Apple. Here's what the experts determined about the company's stock rally.
Via
Benzinga
A New Name in Weight Loss Drugs
May 28, 2024
Novo Nordisk and Eli Lilly have soared on the popularity of GLP-1 weight loss drugs. Now Hims & Hers is trying to get in on the action with a more available and affordable option.
Via
The Motley Fool
OZEM ETF: 7 Things to Know About the New Roundhill GLP-1 & Weight Loss ETF
May 28, 2024
As weight loss drugs are gaining popularity Roundhill GLP 1 And Weight Loss ETF (OZEM) has launched as anew way to invest in them.
Via
InvestorPlace
Topics
ETFs
The Dividend Acceleration Squad: 3 Stocks With Rapidly Rising Yields
May 28, 2024
Dividend stocks that grow their returns faster than others are worth considering for investors interested in growing their incomes.
Via
InvestorPlace
LifeMD Can Surge on Its GLP-1 Offerings
May 28, 2024
LifeMD is a leading telehealth provider that investors should take note of; the company is entering the GLP-1 market, and its stock could soar as a result
Via
MarketBeat
Soaring Eli Lilly Stock Could Climb Another 24% According to a Wall Street Analyst. Is the Stock a Buy Now?
May 28, 2024
Plowing $9 billion into a manufacturing facility could help a successful tirzepatide launch reach new heights.
Via
The Motley Fool
'Not Just A Weight Loss Story:' Eli Lilly CEO Thinks It's Possible To Meet BofA's $60B Revenue Projection From New Drug Launches
May 28, 2024
Ricks highlighted that the company is trying to prove the efficacy of its drugs for not only weight loss but also obesity-driven diseases such as heart risks, diabetes, and sleep apnea.
Via
Benzinga
The Penny Stock Prophecy: 3 Overlooked Stocks Primed to Pop
May 27, 2024
Overlooked penny stocks are the path to outsized gains and these shares seem to fit the bill at the moment.
Via
InvestorPlace
10 Best Vanguard Funds to Buy Right Now
May 27, 2024
These 10 Vanguard stock ETFs can help you build a top-notch portfolio.
Via
The Motley Fool
Topics
ETFs
Chinese Scientists Achieve World's First Diabetes Cure Using Cell Therapy: Report
May 27, 2024
A team of Chinese scientists has successfully cured a patient's diabetes using cell therapy, marking a global first.
Via
Benzinga
Got $500? 3 Pharma Stocks to Buy and Hold Forever
May 26, 2024
These players might even beat the market when the conditions are right.
Via
The Motley Fool
Amgen's Catching Up to Novo Nordisk and Eli Lilly. Should You Buy It?
May 26, 2024
The gold rush for obesity medications just got a bit more intense.
Via
The Motley Fool
3 High-Flying Stocks That Could Soar Even More
May 25, 2024
The momentum should continue for Eli Lilly, Novo Nordisk, and Vertex Pharmaceuticals.
Via
The Motley Fool
Elon Musk Says Ozempic 'Will Become Very Cheap' After New Comedy Special Paints It As Weight Loss Drug Only Wealthy People Can Afford
May 25, 2024
Elon Musk predicts that Novo Nordisk's weight-loss drug Ozempic will eventually become very cheap, following its depiction in a new South Park special as a luxury medication accessible only to the...
Via
Benzinga
Eli Lilly Makes Largest Manufacturing Investment In Its History To Boost Production For Antidiabetic And Weight Loss Meds
May 24, 2024
Eli Lilly has significantly increased its investment in its Lebanon, Indiana, manufacturing site to $9 billion, aiming to enhance production of tirzepatide injections.
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
May 24, 2024
Via
Benzinga
< Previous
1
2
...
17
18
19
20
21
22
23
24
25
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.